Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Devin Peipert

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|March 3, 2026
Patient-Reported Outcomes to Inform Tolerability Characterization in Cancer Trials: A Critical Perspective on Unresolved Methodological IssuesBill Byrom, John Devin Peipert
Kidney Medicine|August 17, 2021
Importance of Patient-Reported Outcome Measures on Clinical Practice in Patients With Kidney DiseaseRebecca Frazier, John Devin Peipert
Interventional Pain Medicine|September 6, 2024
Response to: "Criteria for determining if a treatment for pain works"Ron D Hays, John Devin Peipert
Progress in Transplantation (Aliso Viejo, Calif.)|April 28, 2018
An Explore Transplant Group Randomized Controlled Education Trial to Increase Dialysis Patients' Decision-Making and Pursuit of TransplantationAmy D Waterman, John Devin Peipert
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2022
Reconsidering tolerability of cancer treatments: opportunities to focus on the patientJohn Devin Peipert, Mary Lou Smith,
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 13, 2022
Correction to: Reconsidering tolerability of cancer treatments: opportunities to focus on the patientJohn Devin Peipert, Mary Lou Smith,
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 15, 2021
Between-group minimally important change versus individual treatment respondersRon D Hays, John Devin Peipert
BMJ Oncology|June 23, 2025
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical careMelanie Calvert, Roger Wilson, John Devin Peipert
Journal of Patient-Reported Outcomes|March 21, 2024
The challenge of using patient reported outcome measures in clinical practice: how do we get there?David Cella, Kyle Nolla, John Devin Peipert
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 3, 2022
Likely change indexes improve estimates of individual change on patient-reported outcomesJohn Devin Peipert, Ron D Hays, David Cella
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Cancer Control : Journal of the Moffitt Cancer Center|March 3, 2026
Patient-Reported Outcomes to Inform Tolerability Characterization in Cancer Trials: A Critical Perspective on Unresolved Methodological IssuesBill Byrom, John Devin Peipert
Kidney Medicine|August 17, 2021
Importance of Patient-Reported Outcome Measures on Clinical Practice in Patients With Kidney DiseaseRebecca Frazier, John Devin Peipert
Interventional Pain Medicine|September 6, 2024
Response to: "Criteria for determining if a treatment for pain works"Ron D Hays, John Devin Peipert
Progress in Transplantation (Aliso Viejo, Calif.)|April 28, 2018
An Explore Transplant Group Randomized Controlled Education Trial to Increase Dialysis Patients' Decision-Making and Pursuit of TransplantationAmy D Waterman, John Devin Peipert
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2022
Reconsidering tolerability of cancer treatments: opportunities to focus on the patientJohn Devin Peipert, Mary Lou Smith,
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 13, 2022
Correction to: Reconsidering tolerability of cancer treatments: opportunities to focus on the patientJohn Devin Peipert, Mary Lou Smith,
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 15, 2021
Between-group minimally important change versus individual treatment respondersRon D Hays, John Devin Peipert
BMJ Oncology|June 23, 2025
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical careMelanie Calvert, Roger Wilson, John Devin Peipert
Journal of Patient-Reported Outcomes|March 21, 2024
The challenge of using patient reported outcome measures in clinical practice: how do we get there?David Cella, Kyle Nolla, John Devin Peipert
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 3, 2022
Likely change indexes improve estimates of individual change on patient-reported outcomesJohn Devin Peipert, Ron D Hays, David Cella
Pageof 9